Literature DB >> 21714317

Optimizing Canadian public immunization programs: a prescription for action.

David W Scheifele1, Monika Naus, Natasha S Crowcroft, Simon Dobson, Scott A Halperin, Gordean Bjornson.   

Abstract

Recent expansion of public vaccination programs for children and youth offers new health benefits but at substantially increased cost. As with other large public investments, immunization programs ought to be systematically evaluated for safety, effectiveness and economic value. At present, program evaluations are suboptimal in most provinces and territories. Experts in public health and vaccinology who attended a workshop in 2009 reviewed the shortcomings and produced "prescriptions for action" to improve matters. Six key recommendations were made: 1) a formal requirement should exist to evaluate all public vaccination programs appropriately; 2) greater voluntary harmonization of programs will facilitate evaluations; 3) a mechanism is needed to prioritize and coordinate program-specific evaluations; 4) new funding mechanisms are needed for basic jurisdictional studies and joint studies of broad relevance; 5) strong emphasis is needed on capacity development and training; and 6) administrative barriers to accessing health information systems and publishing evaluation studies need to be overcome. The expert group considered the need to improve program evaluations as urgent and compelling, with success achievable with dedicated funding and effective leadership. Demonstrating that Canadian immunization programs are among the world's best and safest is a sound strategy for maintaining public participation in those programs.

Entities:  

Mesh:

Year:  2011        PMID: 21714317      PMCID: PMC6973966     

Source DB:  PubMed          Journal:  Can J Public Health        ISSN: 0008-4263


  4 in total

1.  An analytical framework for immunization programs in Canada.

Authors:  L J Erickson; P De Wals; L Farand
Journal:  Vaccine       Date:  2005-03-31       Impact factor: 3.641

2.  Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States.

Authors:  Sandra W Roush; Trudy V Murphy
Journal:  JAMA       Date:  2007-11-14       Impact factor: 56.272

3.  The impact of childhood meningococcal serogroup C conjugate vaccine programs in Canada.

Authors:  Julie A Bettinger; David W Scheifele; Nicole Le Saux; Scott A Halperin; Wendy Vaudry; Raymond Tsang
Journal:  Pediatr Infect Dis J       Date:  2009-03       Impact factor: 2.129

4.  The effect of routine vaccination on invasive pneumococcal infections in Canadian children, Immunization Monitoring Program, Active 2000-2007.

Authors:  Julie A Bettinger; David W Scheifele; James D Kellner; Scott A Halperin; Wendy Vaudry; Barbara Law; Gregory Tyrrell
Journal:  Vaccine       Date:  2009-12-29       Impact factor: 3.641

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.